1. Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study
   Zilin Qin et al, 2017, Cancer Biology & Therapy CrossRef
2. Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1
   Steffen Rausch et al, 2015, Urologic Oncology: Seminars and Original Investigations CrossRef
3. Enzymes as Diagnostic Tools
   Ram Sarup Singh et al, 2019, Advances in Enzyme Technology CrossRef
4. A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management
   Kiran Kumar Jagarlamudi et al, 2015, PLOS ONE CrossRef
5. Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker
   Kiran Kumar Jagarlamudi et al, 2018, Biomarkers in Medicine CrossRef
6. A meta‑analysis of serological thymidine kinase 1 as a marker for colorectal benign and malignant tumor risk assessment
   Li Dang et al, 2020, Molecular and Clinical Oncology CrossRef
7. Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker
   Kiran Kumar Jagarlamudi et al, 2015, BMC Cancer CrossRef
8. A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease
   J. Kiran Kumar et al, 2016, Tumor Biology CrossRef
9. Increased serum level of thymidine kinase 1 correlates with metastatic site in patients with malignant melanoma
   Bao-Jin Wu et al, 2013, Tumor Biology CrossRef
10. Serum Thymidine Kinase 1 Activity in Solid Tumor (Breast and Colorectal Cancer) Patients Treated With Adjuvant Chemotherapy
    M. Bolayirli et al, 2013, Journal of Clinical Laboratory Analysis CrossRef
11. Enzymes as indispensable markers in disease diagnosis
    Shehabaz Usman Pathan et al, 2024, Bioanalysis CrossRef
12. Development of a gold nanoparticle-based lateral flow immunochromatographic assay for the rapid and quantitative detection of thymidine kinase 1 in human serum
    Liya Ye et al, 2024, Journal of Pharmaceutical and Biomedical Analysis CrossRef
13. Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker
    Jianjun Wang et al, 2017, Tumor Biology CrossRef
14. Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence
    Wei Zhang et al, 2017, World Journal of Gastroenterology CrossRef
15. Serum thymidine kinase 1 protein concentrations and presence of its autoantibody as biomarkers for screening dogs with malignant tumors
    Yoonhee Kim et al, 2024, Journal of Veterinary Internal Medicine CrossRef